Delisting From Liver Transplant List for Improvement and Recompensation Among Decompensated Patients at One Year
ALD and HBV are most frequent etiologies for delisting due to liver disease improvement. About 10% of delisted patients develop recompensation, with HBV etiology most likely to recompensate. Models and biomarkers are needed to identify these candidates for optimal use of deceased donor livers.
Authors
- Gene Y. Im (ORCID: https://orcid.org/0000-0003-0009-8418)
- Yong‐Fang Kuo (ORCID: https://orcid.org/0000-0003-1927-0927)
- Juan Pablo Arab (ORCID: https://orcid.org/0000-0002-8561-396X)
- Ashwani Kumar Singal (ORCID: https://orcid.org/0000-0003-1207-3998)
- Deepan Pannerselvam
Institutions
- Western University (CA)
- University of Louisville (US)
- University of South Dakota (US)
- University of Sioux Falls (US)
- London Health Sciences Centre (CA)
- Jewish Hospital (US)
- Louisville VA Medical Center (US)
- The University of Texas Medical Branch at Galveston (US)
- Jewish Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.14309/ajg.0000000000003259
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55